Systematic (IUPAC) name | |
---|---|
4-[4-(2-oxo-3-propanoyl-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Routes | Oral |
Identifiers | |
CAS number | 15301-48-1 |
ATC code | N02AC05 |
PubChem | CID 61791 |
DrugBank | DB01459 |
ChemSpider | 55675 |
UNII | 3KXW0Y310I |
Chemical data | |
Formula | C31H32N4O2 |
Mol. mass | 492.611 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Bezitramide is a narcotic analgesic. Bezitramide itself is a prodrug which is readily hydrolyzed in the gastrointestinal tract to its main metabolite, despropionyl-bezitramide. Bezitramide was discovered at Janssen Pharmaceutica in 1961[1][2][3]. It is most commonly marketed under the trade name Burgodin.
The drug was pulled from the shelves in the Netherlands in 2004 after fatal overdose cases, including one where a five year old child took one tablet from his mother's purse, ate it, and promptly died.[4]
Bezitramide is regulated much the same as morphine in all known jurisdictions and is a Schedule II substance under the United States' Controlled Substances Act of 1970.[5] However, it has to this point never been marketed in the United States.